Archives for April 2008
NeuroMetrix Receives FDA 510(k) Clearance for Advance
Long beleaguered NeuroMetrix, which has seen its stock price erode as officials investigate the marketing and misuse of its NC-stat System, received FDA 510(k) clearance for the Advance System this week. Shares of the Waltham, MA-based company nearly doubled on the news, to a high of $3.06 on Monday.
Advance is a platform for performing nerve […]
[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies
ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines.
VacciMax technology is based on a novel approach to the use of liposomes. While liposomes typically contribute only marginally to the production of an immune response, IVT has discovered that liposomes stabilized by VacciMax technology significantly enhance antibody production.
The company believes […]
Merit Medical: Shows Resilience in Faltering Economy; Positioned for Continued Growth
The healthcare equipment sector has a history of resilience. The sector remained strong during the economic downturn earlier this decade and appears to be holding its own now. An aging demographic virtually guarantees increased demand for healthcare supplies.
Not surprisingly, the sector is also highly competitive. J&J, Boston Scientific and Medtronic are industry behemoths with a […]
Yulex Receives FDA 510(k) Clearence for Novel Rubber Glove
Latex glove use increased dramatically in the eighties largely as an outgrowth of the AIDS epidemic. Almost unheard of 20 years ago, researchers now estimate that 8% - 12% of healthcare workers have developed allergies to traditional latex.
In one well-cited study of blood donors, more than 6% had evidence of latex antibodies. Extrapolated to the […]
Biophan Moves Forward with Myotech CSS Development
Pittsford, NY-based Biophan Technologies, will move forward with the next phase of the Myotech Circulatory Support System (CSS) engineering and regulatory development program.
The company’s board released $2 million to support efforts which will bring the product closer to commercialization. According to the company, Myotech CSS could be on the market within 24 to 30 months.
The […]
OccuLogix Looks to Tears, Hopes to Survive Difficulties
OccuLogix, which traded as high as $1.63 just one year ago, has seen its share price erode as investors lose confidence in the company and its management. OccuLogix has consistently failed to execute general corporate strategy. The company, which faces NASDAQ delisting, opened at $.22 this morning.
In 2007, the company’s recorded a net loss of […]
Maryland Medicaid Approves ActiPatch Technology for Kidney Compromised Patients
Patients with kidney disease often avoid common pain relievers like aspirin, ibuprofen and naproxen. These medications have the potential to exacerbate existing conditions and create life-threatening drug interactions. As an alternative to drug-based relief for kidney-compromised patients, Maryland Medicaid will now offer reimbursement for BioElectronics’ ActiPatch.
ActiPatch is a drug-free anti-inflammatory patch which accelerates healing while […]
[Video Profile] Interview with Leah Sparks, VP Business Development of DNA Direct
Medical professional societies have mandated that genetic tests be ordered by a physician and interpreted by a genetic counselor, geneticist, or other specialist. In some states, genetic testing must be accompanied by an in-person genetics evaluation or genetic counseling appointment.
This approach is limited by the fact that there are only 1,200 medical geneticists and […]
CryoLife to Distribute Medafor Hemostatic Agent
CryoLife, in a three-year agreement signed last week, will become the exclusive U.S. distributor of Minneapolis, MN-based Medafor’s microporous polysaccharide hemostatic (MPH) agent for use in cardiac and vascular surgeries.
CryoLife will also offer MPH outside of the U.S. (excluding Japan and China) in cardiac, vascular and general surgical procedures but not in orthopedic or ENT […]
Boston Scientific to Acquire CryoCor
Boston Scientific will acquire CryoCor for $17.6 million in cash or $1.35 per share. The buyout comes after a tumultuous year for the San Diego-based company; CryoCor stock traded as high as $7.20 prior to regulatory difficulties.
CryoCor suffered a blow in June when it learned that FDA was unhappy with its pre-market approval (PMA) application […]
